nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activity of interferon-α in relapsed patients with diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma
|
Armitage, J. O. |
|
2000 |
11 |
3 |
p. 359-361 |
artikel |
2 |
A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenous infusion in patients with advanced solid tumors
|
Tolcher, A. W. |
|
2000 |
11 |
3 |
p. 333-338 |
artikel |
3 |
A. V. Kaisary, G. P. Murphy, L. Denis et al. (eds.), Textbook of Prostate Cancer. Pathology, Diagnosis and Treatment
|
De Cobelli, O. |
|
2000 |
11 |
3 |
p. 252 |
artikel |
4 |
Characterization of dihydropyrimidine dehydrogenase on immunohistochemistry in colon carcinoma, and correlation between immunohistochemical score and protein level or messenger RNA expression
|
Takenoue, T. |
|
2000 |
11 |
3 |
p. 273-279 |
artikel |
5 |
Docetaxel (Taxotere®)–cisplatin (TC): An effective drug combination in gastric carcinoma
|
Roth, A. D. |
|
2000 |
11 |
3 |
p. 301-306 |
artikel |
6 |
Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas
|
Zinzani, P. L. |
|
2000 |
11 |
3 |
p. 363-365 |
artikel |
7 |
EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells
|
Casamassimi, A. |
|
2000 |
11 |
3 |
p. 319-325 |
artikel |
8 |
Eight-hour infusion versus bolus injection of doxorubicin in the EAP regimen in patients with advanced gastric cancer: A prospective randomised trial
|
Popov, I. |
|
2000 |
11 |
3 |
p. 343-348 |
artikel |
9 |
Endometrial mesodermal mixed tumor occurring after tamoxifen treatment: Report on a new case and review of the literature
|
Dumortier, J. |
|
2000 |
11 |
3 |
p. 355-358 |
artikel |
10 |
Estimation of dihydropyrimidine dehydrogenase activity: Does it have a role in cancer therapy?
|
Collie-Duguid, E. S. R. |
|
2000 |
11 |
3 |
p. 255-257 |
artikel |
11 |
Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours
|
Imam, H. |
|
2000 |
11 |
3 |
p. 295-300 |
artikel |
12 |
Germ-cell tumors in childhood and adolescence
|
Göbel, U. |
|
2000 |
11 |
3 |
p. 263-271 |
artikel |
13 |
M. R. S. Keshtgar, W. A. Waddington, S. R. Lakhani et al. (eds)., The Sentinel Node in Surgical Oncology
|
Gennari, R. |
|
2000 |
11 |
3 |
p. 376 |
artikel |
14 |
MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)
|
Toffoli, G. |
|
2000 |
11 |
3 |
p. 373-374 |
artikel |
15 |
NCIC–CTG phase II study of gemcitabine in patients with malignant glioma (IND.94)
|
Gertler, S. Z. |
|
2000 |
11 |
3 |
p. 315-318 |
artikel |
16 |
Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic study
|
Hong, R.-L. |
|
2000 |
11 |
3 |
p. 349-354 |
artikel |
17 |
Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer
|
Caponigro, F. |
|
2000 |
11 |
3 |
p. 339-342 |
artikel |
18 |
Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome
|
Foulkes, W. D. |
|
2000 |
11 |
3 |
p. 307-313 |
artikel |
19 |
Proposing phase I studies: Patients', relatives', nurses' and specialists' perceptions
|
Tomamichel, M. |
|
2000 |
11 |
3 |
p. 289-294 |
artikel |
20 |
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
|
Tropé, C. |
|
2000 |
11 |
3 |
p. 281-288 |
artikel |
21 |
Relevance of DNA-ploidy as a prognostic instrument for solid tumors
|
Silvestrini, R. |
|
2000 |
11 |
3 |
p. 259-261 |
artikel |
22 |
R. E. Scully (ed)., Histological Typing of Ovarian Tumours
|
Sessa, C. |
|
2000 |
11 |
3 |
p. 251 |
artikel |
23 |
Rituximab: Active treatment of central nervous system involvement by non-Hodgkin's lymphoma?
|
Ruhstaller, T. W. |
|
2000 |
11 |
3 |
p. 374-375 |
artikel |
24 |
The urokinase-type plasminogen activator system in resected non-small-cell lung cancer
|
Salden, M. |
|
2000 |
11 |
3 |
p. 327-332 |
artikel |
25 |
US admits cancer victims among nuclear arms workers; NHS remains in the limelight; 'Globalizers' most worried about global warming; After 50 years, the Dutch Cancer Society enters a new era; Health Care: A top issue for US Democrats in the election year; Perhaps not everyone knows that...
|
|
|
2000 |
11 |
3 |
p. 245-251 |
artikel |
26 |
Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: A parallel dose-finding study
|
Frasci, G. |
|
2000 |
11 |
3 |
p. 367-371 |
artikel |
27 |
World summit against cancer for the new millennium: The Charter of Paris
|
Kerr, D. |
|
2000 |
11 |
3 |
p. 253-254 |
artikel |